Table of Contents
Chapter 1. Global Oral Transmucosal Drugs Market Executive Summary
1.1. Global Oral Transmucosal Drugs Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Route of Administration
1.3.3. By Indication
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Oral Transmucosal Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Oral Transmucosal Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Rising Demand for Oral Transmucosal Drugs
3.1.2. Advancements in Drug Delivery Technologies
3.1.3. Increasing Prevalence of Chronic Diseases
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements for Drug Approval and Commercialization
3.2.2. High Cost Associated with Research and Development Activities
3.3. Market Opportunities
3.3.1. Favorable Regulatory Environments
3.3.2. Investments in Pharmaceutical R&D
3.3.3. Emerging Markets in various economies
Chapter 4. Global Oral Transmucosal Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Oral Transmucosal Drugs Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Oral Transmucosal Drugs Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Tablets
5.2.2. Films
5.2.3. Liquid & Spray
5.2.4. Other Product Types
Chapter 6. Global Oral Transmucosal Drugs Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Oral Transmucosal Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Sublingual Mucosa
6.2.2. Buccal Mucosa
6.2.3. Other Routes of Administration
Chapter 7. Global Oral Transmucosal Drugs Market Size & Forecasts by Indication 2022-2032
7.1. Segment Dashboard
7.2. Global Oral Transmucosal Drugs Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Opioid Dependence
7.2.2. Nausea and Vomiting
7.2.3. Erectile Dysfunction
7.2.4. Neurological Disorders
7.2.5. Other Indications
Chapter 8. Global Oral Transmucosal Drugs Market Size & Forecasts by Distribution Channel 2022-2032
8.1. Segment Dashboard
8.2. Global Oral Transmucosal Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Global Oral Transmucosal Drugs Market Size & Forecasts by Region 2022-2032
9.1. North America Oral Transmucosal Drugs Market
9.1.1. U.S. Oral Transmucosal Drugs Market
9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
9.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
9.1.1.3. Indication breakdown size & forecasts, 2022-2032
9.1.1.4. Distribution Channel breakdown size & forecasts, 2022-2032
9.1.2. Canada Oral Transmucosal Drugs Market
9.2. Europe Oral Transmucosal Drugs Market
9.2.1. U.K. Oral Transmucosal Drugs Market
9.2.2. Germany Oral Transmucosal Drugs Market
9.2.3. France Oral Transmucosal Drugs Market
9.2.4. Spain Oral Transmucosal Drugs Market
9.2.5. Italy Oral Transmucosal Drugs Market
9.2.6. Rest of Europe Oral Transmucosal Drugs Market
9.3. Asia-Pacific Oral Transmucosal Drugs Market
9.3.1. China Oral Transmucosal Drugs Market
9.3.2. India Oral Transmucosal Drugs Market
9.3.3. Japan Oral Transmucosal Drugs Market
9.3.4. Australia Oral Transmucosal Drugs Market
9.3.5. South Korea Oral Transmucosal Drugs Market
9.3.6. Rest of Asia Pacific Oral Transmucosal Drugs Market
9.4. Latin America Oral Transmucosal Drugs Market
9.4.1. Brazil Oral Transmucosal Drugs Market
9.4.2. Mexico Oral Transmucosal Drugs Market
9.4.3. Rest of Latin America Oral Transmucosal Drugs Market
9.5. Middle East & Africa Oral Transmucosal Drugs Market
9.5.1. Saudi Arabia Oral Transmucosal Drugs Market
9.5.2. South Africa Oral Transmucosal Drugs Market
9.5.3. Rest of Middle East & Africa Oral Transmucosal Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Aquestive Therapeutics, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Jazz Pharmaceuticals, plc.
10.3.3. Pfizer Inc.
10.3.4. C.L.Pharm Co., Ltd.
10.3.5. Cure Pharmaceutical.
10.3.6. IntelGenx Technologies Corp.
10.3.7. NAL Pharma
10.3.8. Novartis AG
10.3.9. Teva Pharmaceutical Industries Limited.
10.3.10. ZIM Laboratories Limited
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes